Linda Karen Atkinson

US Patent:

49485938, Aug 14, 1990

Filed:

May 15, 1989

Appl. No.:

7/351365

Inventors:

Jeri D. Wright - Dublin CA
Jerry D. Childers - Fremont CA
Brian L. Barcley - Sunnyvale CA
Patrick S. L. Wong - Palo Alto CA
Linda E. Atkinson - Portola Valley CA

Assignee:

Alza Corporation - Palo Alto CA

International Classification:

A61K 922

US Classification:

424473

Abstract:

An osmotic device is disclosed comprising an estrogenic and a progestogenic steroid that are delivered as a contraceptive pair for fertility regulation in a female.

US Patent:

51223821, Jun 16, 1992

Filed:

Oct 29, 1990

Appl. No.:

7/605726

Inventors:

Robert M. Gale - Los Altos CA
Diane E. Nedberge - Los Altos CA
Linda E. Atkinson - Portola Valley CA

Assignee:

ALZA Corporation - Palo Alto CA

International Classification:

A61F 1340

US Classification:

424449

Abstract:

The present invention provides compositions and methods for the transdermal administration of a contraceptively effective amount of a synthetic 19-nor-progesterone (ST-1435) and an estrogen, in combination, together with a suitable permeation enhancer.

US Patent:

58424768, Dec 1, 1998

Filed:

May 9, 1995

Appl. No.:

8/437758

Inventors:

Jeri Dawn Wright - Dublin CA
Jerry D. Childers - Fremont CA
Brian L. Barclay - Sunnyvale CA
Patrick S.-L. Wong - Palo Alto CA
Linda E. Atkinson - Portola Valley CA

Assignee:

ALZA Corporation - Palo Alto CA

International Classification:

A61B 1900
A61K 924

US Classification:

128898

Abstract:

An osmotic device is disclosed comprising an exterior coat comprising an estrogenic and a progestogenic steroid that are delivered immediately as a contraceptive pair for fertility regulation in a female, and a compartment comprising an estrogenic steroid that is delivered at a controlled rate over a prolonged period of time for fertility regulation in a female.

US Patent:

52001970, Apr 6, 1993

Filed:

Dec 9, 1991

Appl. No.:

7/805241

Inventors:

Jeri D. Wright - Dublin CA
Jerry D. Childers - Fremont CA
Brian L. Barclay - Sunnyvale CA
Patrick S.-L. Wong - Palo Alto CA
Linda E. Atkinson - Portola Valley CA

Assignee:

Alza Corporation - Palo Alto CA

International Classification:

A61K 924

US Classification:

424473

Abstract:

An osmotic device is disclosed comprising an exterior coat comprising an estrogenic and a progestogenic steroid that are delivered immediately as a contraceptive pair for fertility regulation in a female, and a compartment comprising an estrogenic steroid that is delivered at a controlled rate over a prolonged period of time for fertility regulation in a female.

US Patent:

54434610, Aug 22, 1995

Filed:

Aug 31, 1993

Appl. No.:

8/114800

Inventors:

Linda E. Atkinson - Portola Valley CA
John T. Dunn - Palo Alto CA
Robert M. Gale - Los Altos CA
David L. Rivera - San Jose CA

Assignee:

ALZA Corporation - Palo Alto CA

International Classification:

A61K 922

US Classification:

6048921

Abstract:

Diffusional delivery devices are constructed in two or more compartments, each containing a separate drug or other beneficial agent, and each arranged to permit diffusion of the agent out of the device through an individually-characterized agent-permeable wall segment. The diffusion rates of the various agents relative to one another are set and controlled by the parameters of the individual wall segments, such as the surface area of the wall segment, the average thickness of the wall segment, and the permeability of the wall segment for the particular agent. The permeability may be varied by variations in the chemical composition of the wall segment. Using these parameters rather than blending the agents at calculated ratios in a single formulation for diffusion through a single wall permits a wider range of, and greater flexibility in, variation between the diffusion rates of the different agents. This is of value when the simultaneous administration of agents at a specified ratio is desired.

US Patent:

51982234, Mar 30, 1993

Filed:

Mar 9, 1992

Appl. No.:

7/848578

Inventors:

Robert M. Gale - Los Altos CA
Diane E. Nedberge - Los Altos CA
Linda E. Atkinson - Portola Valley CA

Assignee:

Alza Corporation - Palo Alto CA

International Classification:

A61F 1300

US Classification:

424449

Abstract:

The present invention provides compositions and methods for the transdermal administration of a therapeutically effective amount of a synthetic 19-nor-progesterone (ST-1435) and an estrogen, in combination, together with, optionally, a suitable permeation enhancer.

US Patent:

53208501, Jun 14, 1994

Filed:

Feb 12, 1993

Appl. No.:

8/016627

Inventors:

Robert M. Gale - Los Altos CA
Diane E. Nedberge - Los Altos CA
Linda E. Atkinson - Portola Valley CA

Assignee:

ALZA Corporation - Palo Alto CA

International Classification:

A61F 1300

US Classification:

424449

Abstract:

The present invention provides compositions and methods for the transdermal administration of a therapeutically effective amount of a synthetic 19-nor-progesterone (ST-1435) together with, optionally, a suitable permeation enhancer.

US Patent:

55957595, Jan 21, 1997

Filed:

Nov 10, 1994

Appl. No.:

8/337701

Inventors:

Jeri D. Wright - Dublin CA
Brian L. Barclay - Sunnyvale CA
Linda E. Atkinson - Portola Valley CA

Assignee:

Alza Corporation - Palo Alto CA

International Classification:

A61K 920

US Classification:

424464

Abstract:

A process is disclosed and claimed for preparing a therapeutic composition comprising asteroid or a dosage form comprising the composition, which therapeutic composition or dosage form is indicated for human administration.